Wednesday, September 27th

Program Schedule

Click on session titles for details
Start End Session Location
08:30 10:00 Saga Hall
Moderators: John O’Shea, National Institutes of Health
Ewa Sitnicka, Lund University
Andreas Diefenbach, Charité Berlin
Innate lymphoid cells and tissue remodeling
Barbara Kee, University of Chicago
ETS all about NK cells and innate lymphocytes
Joseph Sun, Memorial Sloan Kettering Cancer Center
Fasting reshapes tissue-specific NK cell immunity
Sebastian Scheer, Luxembourg Institute of Health
The methyltransferase DOT1L controls NK cell activation and lineage integrity.
Stephanie Jost, Duke University
Adaptive NK cells responses against antigenically distinct influenza viruses are partly mediated by HLA-E-stabilizing peptides derived from conserved antigens
Everardo Hegewisch-Solloa, Columbia University Irving Medical Center
A multifaceted deep dive into the NK cell developmental niche within human secondary lymphoid tissue.
10:00 10:30 Coffee Break Foyer
10:30 12:00 Saga Hall
Moderators: Michael Caligiuri, City of Hope National Medical Center
Cynthia Dunbar, National Institutes of Health
Nicolas Serafini, Institut Pasteur
Intestinal ILC3: Better, Faster, Stronger
Chiara Romagnani, Charité University and DRFZ Berlin
Dynamics of human NK cell memory and clonality
Yenan Bryceson, Karolinska Institutet
To be announced
Helena Arellano Ballestero, University College London
Tumour-priming induces memory-like properties on NK cells: characterisation of the proteomic and receptor profile
Ming Cheng, University of Science and Technology of China
Transcription factor ROR-alpha promotes the formation and long-term maintenance of memory ILC1s
Markus Uhrberg, Heinrich-Heine University Düsseldorf
A novel human NK cell progenitor that originates in the thymus and generates NKG2A-KIR+ NK cells
12:00 13:30 Lunch Restaurant
13:30 15:00 Saga Hall
Moderators: Dimitra Peppa, University College London
Quirin Hammer, Karolinska Institutet
Mariapia Degli-Eposti, Monash University
To be announced
Catherine Blish, Stanford University
Interrogating human coronavirus escape from and susceptibility to NK cell killing
Stephen Waggoner, Cincinnati Children's Hospital Medical Center
Using forensic victimology and immunological gun control to stop a follicular murder
Simon Grassman, Memorial Sloan Kettering Cancer Center
Early antigen-receptor signaling primes NK cells for optimal cytokine signaling during infection
Jesse Bruijnesteijn, Biomedical Primate Research Centre
Chromosomal rearrangements in the KIR gene cluster as evolutionary strategy to fight fast evolving pathogens
Wilfredo Garcia-Beltran, Ragon Institute of Mass General, MIT and Harvard
SARS-CoV-2 evades NK-cell immunity by ORF6-mediated shedding of NKG2D ligands, uncovering a novel immunotherapeutic target conserved among sarbecoviruses
15:00 15:30 Coffee Break Foyer
15:30 16:40 Saga Hall
Moderators: Marcus Altfeld, Leibniz Institute for Virology
Clair Gardiner, Trinity College Dublin
Mary Carrington, Frederick National Laboratory for Cancer Research
Impact of HLA class I Signal Peptide Variation on HLA-E interactions with CD94/NKG2A
Marit Inngjerdingen, University of Oslo
Unravelling the heterogeneity of extracellular vesicles released from NK cells
Patrick Ross, San Diego Biomedical Research Institute
Leveraging MINFLUX Nanoscopy to Understand NK Cell Immunological Synapse Structure and Dynamics
Anzelika Rubina, Cardiff University
Human cytomegalovirus genes UL148 and UL148D inhibit NK cell function by promoting surface expression of inhibitory ligands via impairment of ADAM17
Jean De Lima , University of Basel
Redefining the lung immune cell network: crosstalkbetween HIF-1a+ CD4 T cells and NK cells during influenza infection
16:40 17:10 Saga Hall
Moderators: Amir Horowitz, Mount Sinai
Janine Melsen, Leiden University Medical Center
Giovanna Perinetti Casoni, Karolinska Institutet
DEF6 promotes canonical CD56dim NK cell survival and cytotoxicity
Adriana Mujal, Memorial Sloan Kettering Cancer Center
Tissue-specific determinants of adaptive NK cell responses
Tomas Hofman, Heidelberg University
IFNg- and sialic acid pathways drive melanoma resistance via selective inhibition of NK cell subsets.
Nicole Wild, Karolinska Institutet
Characterisation of organ-specific tissue-resident NK cells across human tissues
Janine Melsen, Leiden University Medical Center
Deciphering human NK cell development using high-dimensional phenotyping and imaging: tonsil versus thymus
Roseanna Hare, University of Manchester
Ligand mobility is necessary for TIGIT to assemble into nanoscale clusters at immune synapses
17:30 20:00 Visit to Fram museum [Ticket Required] Fram
20:00 21:30 Poster Sesson 2, B001-B131 Poster Area

Gold Sponsors

Vycellix Logo
Fate Logo
Sanofi Logo

Silver Sponsors

ScaleReady Logo
MaxCyte Logo

Bronze Sponsors

Zelluna Logo
XNK Logo
Miltenyi Logo
Innate Pharma logo
Oncopeptides Logo
Affimed Logo
ImmuneBridge Logo
CellGenix Logo
Cellmover Logo

Academic Partners

SJI Logo
NextGenNK Logo
Prima Logo
UiO Logo
OUS Logo